{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:22:43Z","timestamp":1784161363808,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011680","name":"King Fahad Medical City","doi-asserted-by":"publisher","award":["022\\u2013005"],"award-info":[{"award-number":["022\\u2013005"]}],"id":[{"id":"10.13039\/501100011680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tvr.2025.200327","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:51:46Z","timestamp":1754430706000},"page":"200327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Transcriptomic profile of the immune genes, oncogenes, and tumor suppressor genes in HPV associated Cervical Intraepithelial Neoplasia 3 (CIN 3) and Cervical Squamous Cell Carcinoma (CSCC): Comparable expressions indicative of invasive potential"],"prefix":"10.1016","volume":"20","author":[{"given":"Maaweya","family":"Awadalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halah Z.","family":"Al Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamah T.","family":"Khojah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia T.","family":"Al-Shouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour I.","family":"Almansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4719-2655","authenticated-orcid":false,"given":"Bandar","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2025.200327_bib1","article-title":"Involvement of human papillomaviruses in cervical cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Microbiol. Rev."},{"key":"10.1016\/j.tvr.2025.200327_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200238","article-title":"Cervical cancer therapies: current challenges and future perspectives","volume":"13","author":"Burmeister","year":"2022","journal-title":"Tumour Virus Res."},{"key":"10.1016\/j.tvr.2025.200327_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.929062","article-title":"Current status of human papillomavirus infection and cervical cancer in the Philippines","volume":"9","author":"Lintao","year":"2022","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.tvr.2025.200327_bib4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s10147-023-02340-y","article-title":"Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body","volume":"28","author":"Egawa","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.tvr.2025.200327_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.molmed.2024.05.009","article-title":"HPV integration and cervical cancer: a failed evolutionary viral trait","volume":"30","author":"Molina","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tvr.2025.200327_bib6","article-title":"Comprehensive analysis of the carcinogenic process, tumor microenvironment, and drug response in HPV-positive cancers","volume":"12","author":"Yu","year":"2022","journal-title":"Front. Oncol. Origin. Res."},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2020.01.023","article-title":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: a population-based cohort study with 80,442 women","volume":"157","author":"Loopik","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.tvr.2025.200327_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"issue":"7629","key":"10.1016\/j.tvr.2025.200327_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.tvr.2025.200327_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0033-8389(01)00007-0","article-title":"Imaging of cancer of the cervix","volume":"40","author":"Scheidler","year":"2002","journal-title":"Radiol. Clin."},{"key":"10.1016\/j.tvr.2025.200327_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156334","article-title":"Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion","volume":"170","author":"Trujillo-Cirilo","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.tvr.2025.200327_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103343","article-title":"Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications","volume":"162","author":"De Nola","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tvr.2025.200327_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2020.10.034","article-title":"HPV post-infection microenvironment and cervical cancer","volume":"497","author":"Yuan","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00262-024-03817-z","article-title":"Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells","volume":"74","author":"Khaliulin","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"23","key":"10.1016\/j.tvr.2025.200327_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235548","article-title":"Comprehensive transcriptome analysis reveals the distinct gene expression patterns of tumor microenvironment in HPV-associated and HPV-non associated tonsillar squamous cell carcinoma","volume":"15","author":"Alahmadi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tvr.2025.200327_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154895","article-title":"MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines\/chemokines and elevated inflammatory innate immune response in the lower respiratory tract","volume":"126","author":"Alosaimi","year":"2020","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.tvr.2025.200327_bib17","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.33033","article-title":"Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention","volume":"147","author":"Pinheiro","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.tvr.2025.200327_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264498","article-title":"High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention","volume":"17","author":"Mbulawa","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.tvr.2025.200327_bib19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ijc.23292","article-title":"Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention","volume":"122","author":"Castellsagu\u00e9","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.tvr.2025.200327_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207619","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.tvr.2025.200327_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/09553002.2017.1362504","article-title":"Cytokine profile of breast cell lines after different radiation doses","volume":"93","author":"Bravat\u00e0","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"issue":"52","key":"10.1016\/j.tvr.2025.200327_bib22","doi-asserted-by":"crossref","first-page":"86522","DOI":"10.18632\/oncotarget.13287","article-title":"Increasing the efficacy of radiotherapy by modulating the CCR2\/CCR5 chemokine axes","volume":"7","author":"Connolly","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.tvr.2025.200327_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/2326-6066.CIR-18-0633","article-title":"CCR2-Dependent recruitment of tregs and monocytes following radiotherapy is associated with TNF\u03b1-Mediated resistance","volume":"7","author":"Mondini","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.tvr.2025.200327_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1008255511404","article-title":"High expression of <em>bcl<\/em>-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia","volume":"9","author":"Karakas","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tvr.2025.200327_bib25","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol. Rev."},{"issue":"2","key":"10.1016\/j.tvr.2025.200327_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","article-title":"The role of Bcl-2 family members in tumorigenesis","volume":"1644","author":"Kirkin","year":"2004","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.tvr.2025.200327_bib27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.gendis.2022.10.019","article-title":"The role of TGF-\u03b2 in the tumor microenvironment of pancreatic cancer","volume":"10","author":"Luo","year":"2023","journal-title":"Gene Dis."},{"issue":"4","key":"10.1016\/j.tvr.2025.200327_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth Factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tvr.2025.200327_bib29","article-title":"The love-hate relationship between TGF-\u03b2 signaling and the immune system during development and tumorigenesis","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol. Rev."},{"issue":"11","key":"10.1016\/j.tvr.2025.200327_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41419-024-07226-z","article-title":"ADAMTS16 drives epithelial-mesenchymal transition and metastasis through a feedback loop upon TGF-\u03b21 activation in lung adenocarcinoma","volume":"15","author":"Xiao","year":"2024","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.tvr.2025.200327_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tvr.2025.200327_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116203","article-title":"Tumor immunotherapy resistance: revealing the mechanism of PD-1\/PD-L1-mediated tumor immune escape","volume":"171","author":"Cui","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.tvr.2025.200327_bib33","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.tvr.2025.200327_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2024.100125","article-title":"PD-L1 and PD-1 in immune regulation and their implications in blood cancers","volume":"11","author":"Shiri Aghbash","year":"2024","journal-title":"Adv. Cancer Biol. Metastasis"},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.tvr.2025.200327_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib37a","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-024-02218-1","article-title":"The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy","volume":"24","author":"Ma","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tvr.2025.200327_bib37b","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/OTT.S505376","article-title":"Profiling the Tumor Immune Microenvironment of HPV-Associated Base of Tongue Squamous Cell Carcinoma","volume":"18","author":"Alahmadi","year":"2025","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.tvr.2025.200327_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/cancers17020248","article-title":"Dynamic multilevel regulation of EGFR, KRAS, and MYC oncogenes: driving cancer cell proliferation through (Epi)Genetic and post-Transcriptional\/Translational pathways","volume":"17","author":"Seres","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.tvr.2025.200327_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1328827","article-title":"Editorial: hallmark of cancer: sustained proliferative signalling","volume":"13","author":"Ciccarone","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13578-019-0361-4","article-title":"Signaling pathways involved in colorectal cancer progression","volume":"9","author":"Koveitypour","year":"2019","journal-title":"Cell Biosci."},{"issue":"5","key":"10.1016\/j.tvr.2025.200327_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101058","article-title":"In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: review","volume":"14","author":"Carrero","year":"2021","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.tvr.2025.200327_bib43","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/ijc.31549","article-title":"Molecular progression to cervical precancer, epigenetic switch or sequential model?","volume":"143","author":"Nedjai","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.tvr.2025.200327_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010373","article-title":"High-grade Cervical Intraepithelial Neoplasia (CIN) associates with increased proliferation and attenuated immune signaling","volume":"23","author":"\u00d8vestad","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679025000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679025000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:35:15Z","timestamp":1772919315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679025000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S2666679025000151"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2025.200327","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic profile of the immune genes, oncogenes, and tumor suppressor genes in HPV associated Cervical Intraepithelial Neoplasia 3 (CIN 3) and Cervical Squamous Cell Carcinoma (CSCC): Comparable expressions indicative of invasive potential","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2025.200327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200327"}}